The role of infectious and seasonal factors in the development of myocardial infarction in men under 60 years old

Abstract

The influence of seasonal and infectious factors on the risk of an unfavorable outcome in the first 56 days of myocardial infarction, a complicated course of the disease, the development of chronic heart failure of the second functional class and higher during this period was studied. The results of examination and treatment of 556 men 19–60 years old with verified type I myocardial infarction were evaluated. The analysis of the risks of an unfavorable outcome, a complicated course of the disease, and the development of chronic heart failure was carried out by the method of multivariate analysis of variance. Chronic foci of infections of the abdominal cavity and kidneys, myocardial infarction in winter, spring and autumn have a moderate negative effect on the prognosis of the disease in the examined. Predictors of unfavorable prognosis are heterogeneous across the seasons. Frequent respiratory infections and chronic inflammatory lung diseases reduce the risk of death in those examined in the first months of myocardial infarction, however, they significantly increase the risk of developing chronic heart failure (bibl.: 19 refs).

Keywords

adverse outcome / complications / foci of infections / heart failure / myocardial infarction / prevention / risk factors / seasonal frequency / young and middle-aged men

References

[1] Garganeeva AA, Okrugin SA, Borel KN. World health organization program «registry of acute myocardial infarction»: capabilities and prospects for studying and predicting outcomes of socially significant diseases. The Siberian medical journal. 2015;30(2):125–130. (In Russ.)

[2] Гарганеева А.А., Округин С.А., Борель К.Н. Программа ВОЗ «Регистр острого инфаркта миокарда» возможности и перспективы в изучении и прогнозировании исходов социально значимых патологий на популяционном уровне // Сибирский медицинский журнал. 2015. Т. 30, № 2. С. 125–130.

[3] Novikov VA, Gulyaev NI, Grechanik PM, Sotnikov AV. Dynamics of clinical manifestations of signs of heart failure in young and middle-aged patients in the long-term period of heart attack. Military Medical Journal. 2009;330(5):68–69. (In Russ.)

[4] Новиков В.А., Гуляев Н.И., Гречаник П.М., Сотников А.В. Динамика клинических проявлений признаков сердечной недостаточности у больных молодого и среднего возраста в отдаленный период инфаркта // Военно-медицинский журнал. 2009. Т. 330, № 5. С. 68–69.

[5] Boytsov SA, Linchak RM, Nedbaikin AM, et al. Epidemiology of sudden cardiac death: what do we know today? Journal of Clinical Practice. 2014;4(20):13–19. (In Russ.)

[6] Бойцов С.А., Линчак Р.М., Недбайкин А.М. и др. Эпидемиология внезапной сердечной смерти: что мы знаем сегодня? // Клиническая практика. 2014. № 4(20). С. 13–19.

[7] Gerber Y, Weston SA, Enriquez-Sarano M, et al. Mortality Associated with Heart Failure After Myocardial Infarction: A Contemporary Community Perspective. Circ Heart Fail. 2016;9(1): e002460. DOI: 10.1161/CIRCHEARTFAILURE.115.002460

[8] Gerber Y., Weston S.A., Enriquez-Sarano M., et al. Mortality Associated with Heart Failure After Myocardial Infarction: A Contemporary Community Perspective // Circ. Heart. Fail. 2016. Vol. 9, No. 1. e002460. DOI: 10.1161/CIRCHEARTFAILURE.115.002460

[9] Boytsov SA, Pogosova NV, Bubnova MG, et al. Cardiovascular prevention 2017 National guidelines. Russ J Cardiol. 2018;23(6): 7–122. (In Russ.) DOI: 10.15829/1560-4071-2018-6-7-122

[10] Бойцов С.А., Погосова Н.В., Бубнова М.Г., и др. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации // Российский кардиологический журнал. 2018. Т. 23, № 6. С. 7–122. DOI: 10.15829/1560-4071-2018-6-7-122

[11] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Glob Heart. 2018;13(4):305–338. DOI: 10.1016/j.gheart.2018.08.004

[12] Thygesen K., Alpert J.S., Jaffe A.S., et al. Fourth Universal Definition of Myocardial Infarction (2018) // Glob. Heart. 2018. Vol. 13, No. 4. P. 305–338. DOI: 10.1016/j.gheart.2018.08.004

[13] Kobalava ZhD, Bobkova IN, Villevalde SV, et al. Cardiovascular risk and chronic kidney disease: strategies for cardionephroprotection. National recommendations. Therapy. 2015;(1):63–96. (In Russ.)

[14] Кобалава Ж.Д., Бобкова И.Н., Виллевальде С.В., и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардионефропротекции. Национальные рекомендации // Терапия. 2015. № 1. С. 63–96.

[15] Gordienko AV, Sotnikov AV, Nosovich DV. The clinical criteria for assessing the quality of life in men of young and middle age in the initial periods of myocardial infarction. The journal of Scientific articles “Health & education millennium”. 2018;20(1):34–44. (In Russ.)

[16] Гордиенко А.В., Сотников А.В., Носович Д.В. Клинические критерии оценки качества жизни у мужчин молодого и среднего возраста в начальные периоды инфаркта миокарда // Журнал научных статей «Здоровье и образование в ХХI веке». 2018. Т. 20, № 1. С. 34–44.

[17] Gordienko AV, Sotnikov AV, Nosovich DV, et al. Interrelation of risk factors of cardiovascular diseases and professional activity in men 60 years with myocardial infarction. Medicine: Theory and Practice. 2017;2(4):19–26. (In Russ.)

[18] Гордиенко А.В., Сотников А.В., Носович Д.В., и др. Взаимосвязь факторов риска кардиоваскулярных заболеваний и профессиональной активности у мужчин моложе 60 лет с инфарктом мио карда // Медицина: теория и практика. 2017. Т. 2, № 4. С. 19–26.

[19] Mareev VYu, Fomin IV, Ageev FT, et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(S6):8–158. (In Russ.) DOI: 10.18087/cardio.2475

[20] Мареев В.Ю., Фомин И.В., Агеев Ф.Т., и др. Рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение // Кардиология. 2018. Т. 58, № S6. С. 8–158. DOI: 10.18087/cardio.2475

[21] Filippov AE, Svistov AS, Lobzin YuV. Dynamics of mortality from coronary heart disease among residents of St. Petersburg over an eight-year period and its relationship with the incidence of acute respiratory infections. Bulletin of the Russian Military Medical Academy. 2005;13(App. 2):129–133. (In Russ.)

[22] Филиппов А.Е., Свистов А.С., Лобзин Ю.В. Динамика смертности от ишемической болезни сердца среди жителей Санкт-Петербурга за восьмилетний период времени и ее связь с заболеваемостью острыми респираторными инфекциями // Вестник Российской военно-медицинской академии. 2005. Т. 13, прил. № 2. С. 129–133.

[23] Lüscher T.F. Risk assessment and management of myocardial infarction. EHJ. 2016;37(13):1005–1007.

[24] Lüscher T.F. Risk assessment and management of myocardial infarction // EHJ. 2016. Vol. 37, No. 13. P. 1005–1007.

[25] Nikitskaya EA, Maryukhnich EV, Savvinova PP, et al. Human herpesviruses and atherosclerosis. Modern point of view. Creative cardio logy. 2015;(2):54–62. (In Russ.) DOI: 10.15275/kreatkard.2015.02.05

[26] Никитская Е.А., Марюхнич Е.В., Савинова П.П., и др. Вирусы герпеса человека и атеросклероз. Современный взгляд // Креативная кардиология. 2015. № 2. С. 54–62. DOI: 10.15275/kreatkard.2015.02.05

[27] Tarasov AV, Kuliashova LB, Zheltakova IR, et al. Diagnostics issues of Chlamydophila Pneumoniae infection in patients with acute coronary syndrome. Russian Journal of Infection and Immunity. 2016;6(1):67–72. (In Russ.) DOI: 10.15789/2220-7619-2016-1-67-72

[28] Тарасов А.В., Куляшова Л.Б., Желтакова И.Р., и др. Особенности диагностики инфекции, вызванной Chlamidophyla Pneumoniae, у больных острым коронарным синдромом // Инфекция и иммунитет. 2016. Т. 6, № 1. С. 67–72. DOI: 10.15789/2220-7619-2016-1-67-72

[29] Sharma A, Ghatge M, Mundkur L, Vangala RK. Translational informatics approach for identifying the functional molecular communicators linking coronary artery disease, infection and inflammation. Mol Med Rep. 2016;13(5):3904–3912. DOI: 10.3892/mmr.2016.5013

[30] Sharma A., Ghatge M., Mundkur L., Vangala R.K. Translational informatics approach for identifying the functional molecular communicators linking coronary artery disease, infection and inflammation // Mol. Med. Rep. 2016. Vol. 13, No. 5. P. 3904–3912. DOI: 10.3892/mmr.2016.5013

[31] Vlachopoulos CV, Terentes-Printzios DG, Aznaouridis KA, et al. Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies. Eur J Prev Cardiol. 2015;22(9):1185–1199. DOI: 10.1177/2047487314549512

[32] Vlachopoulos C.V., Terentes-Printzios D.G., Aznaouridis K.A., et al. Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies // Eur. J. Prev. Cardiol. 2015. Vol. 22, No. 9. P. 1185–1199. DOI: 10.1177/2047487314549512

[33] European Guidelines for the Prevention of Cardiovascular Disease in Clinical Practice (2016 revision). Russ J Cardiol. 2017;22(6): 7–85. (In Russ.) DOI: 10.15829/1560-4071-2017-6-7-85

[34] Европейские рекомендации по профилактике сердечно-сосудистых заболеваний в клинической практике (пересмотр 2016) // Российский кардиологический журнал. 2017. T. 22, No. 6. С. 7–85. DOI: 10.15829/1560-4071-2017-6-7-85

[35] Shlyakhto EV, Konradi AO, Arutyunov GP, et al. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic. Russ J Cardiol. 2020;25(3):129–148. (In Russ.) DOI: 10.15829/1560-4071-2020-3-3801

[36] Шляхто Е.В., Конради А.О., Арутюнов Г.П., и др. Руководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID-19 // Российский кардиологический журнал. 2020. Т. 25, № 3. С. 129–148. DOI: 10.15829/1560-4071-2020-3-3801

[37] Oynotkinova OS, Nikonov EL, Zayratyants OV, et al. Clinical and morphological features of myocardial damage and the course of fulminant myocarditis on the background of СOVID-19, diagnosis and treatment tactics. Vestnik Rossiiskoy Akademii Meditsinskikh Nauk. 2020;75(S5):414–425. (In Russ.) DOI: 10.15690/vramn1433

[38] Ойноткинова О.Ш., Никонов Е.Л., Зайратьянц О.В., и др. Клинические и морфологические особенности повреждения миокарда и течения фульминантного миокардита на фоне СOVID-19, диагностика и тактика лечения // Вестник Российской академии медицинских наук. 2020. Т. 75. № S5. С. 414–425. DOI: 10.15690/vramn1433

RIGHTS & PERMISSIONS

Gordienko A.V., Sotnikov A.V., Nosovich D.V.